Evidence map›Paper›PMID 37630494›Full record

ReviewMicroorganisms2023

Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies.

Asghar Ali, Andaleeb Zahra, Mohan Kamthan, Fohad Mabood Husain, Thamer Albalawi, Mohammad Zubair, Roba Alatawy, Mohammad Abid, Md Salik Noorani

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Genomic Insights ofOpen forum infectious diseases · 2026
    Review
  10. Review
  11. Article
  12. Current Insights into Antibiotic Resistance in UropathogenicAntibiotics (Basel, Switzerland) · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Veterinary world · 2025
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Asghar AliClinical Biochemistry Lab, D/O Biochemistry, School of Chemical and Lifesciences, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0002-1574-4796
Andaleeb ZahraDepartment of Botany, School of Chemical and Lifesciences, Jamia Hamdard, New Delhi 110062, India.ORCID 0009-0005-8850-7184
Mohan KamthanClinical Biochemistry Lab, D/O Biochemistry, School of Chemical and Lifesciences, Jamia Hamdard, New Delhi 110062, India.
Fohad Mabood HusainDepartment of Food Science and Nutrition, College of Food and Agriculture Sciences, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-6598-4328
Thamer AlbalawiDepartment of Biology, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Mohammad ZubairDepartment of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-5787-7845
Roba AlatawyDepartment of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0003-1514-3349
Mohammad AbidDepartment of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.ORCID 0000-0002-0507-8451
Md Salik NooraniDepartment of Botany, School of Chemical and Lifesciences, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0002-1451-2897
Jamia Hamdard · INUniversity of Tabuk · SAJamia Millia Islamia · INKing Saud University · SAPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilms are complex communities of microorganisms that grow on surfaces and are embedded in a matrix of extracellular polymeric substances. These are prevalent in various natural and man-made environments, ranging from industrial settings to medical devices, where they can have both positive and negative impacts. This review explores the diverse applications of microbial biofilms, their clinical consequences, and alternative therapies targeting these resilient structures. We have discussed beneficial applications of microbial biofilms, including their role in wastewater treatment, bioremediation, food industries, agriculture, and biotechnology. Additionally, we have highlighted the mechanisms of biofilm formation and clinical consequences of biofilms in the context of human health. We have also focused on the association of biofilms with antibiotic resistance, chronic infections, and medical device-related infections. To overcome these challenges, alternative therapeutic strategies are explored. The review examines the potential of various antimicrobial agents, such as antimicrobial peptides, quorum-sensing inhibitors, phytoextracts, and nanoparticles, in targeting biofilms. Furthermore, we highlight the future directions for research in this area and the potential of phytotherapy for the prevention and treatment of biofilm-related infections in clinical settings.

Indexed as

anti-biofilmantimicrobial peptideanti-virulence compoundsbiofoulingbioremediationclinical settingsphage therapyplant extractsquorum quenchingquorum sensing

Identifiers

PMID37630494
PMCPMC10459820
OpenAlexW4385421817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.